ICAD To Showcase Its Platform Of Computer-Aided Detection And Advanced Imaging Solutions At RSNA Annual Meeting
Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image
analysis, workflow solutions and radiation therapy for the early
identification and treatment of cancer, today announced that the Company
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will showcase its suite of Computer-Aided Detection (CAD) and advanced imaging solutions at the Radiological Society of North America (RSNA) 99 th Annual Meeting being held December 1-6, 2013 in Chicago. iCAD will feature the SecondLook ® CAD technology for the identification of breast cancer, including the PowerLook ® Advanced Mammography Platform ® featuring iCAD partner Mātakina’s VolparaDensity volumetric breast density assessment software. iCAD’s VeraLook ®, a revolutionary CAD solution for virtual colonoscopy (CTC) designed to enhance clinician accuracy and effectiveness by improving detection of colonic polyps, will also be on display. “The robust display of CAD and imaging solutions showcased in our booth at this year’s RSNA are a testament to iCAD’s proven history and long-time leadership position in the radiology space,” said Ken Ferry, President and CEO of iCAD. “iCAD remains committed to the continued development of advanced technologies, like CAD for 3D tomosynthesis, to meet the needs of our more than 4,800 customers as well as delivering cost-effective, innovative solutions that help radiologists detect cancers with greater confidence.” iCAD offers high-performance, upgradeable CAD systems and workflow solutions for mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). PowerLook AMP provides radiologists with the ability to customize their CAD solution to meet the needs of their individual work environment, including the integration of Mātakina’s VolparaDensity assessment solution, an FDA-cleared technologic advancement providing volumetric breast density measurements that correlate to the BI-RADS breast density category to assist in interpreting digital mammograms. The technology expands on iCAD’s SecondLook Digital algorithm and the CAD metrics feature provides a rich set of clinical decision support tools to aid in mammography screening. Shown to be effective in the detection of colonic polyps, iCAD’s VeraLook CAD solution is designed to integrate with specialized CTC reading environments to streamline the reading process and improve clinician accuracy, productivity, and workflow.